PREDICTORS OF WEIGHT LOSS IN PATIENTS WITH CHRONIC HEART FAILURE AND REDUSED LEFT VENTRICULAR EJECTION FRACTION

Kateryna Voitsekhovska, Leonid Voronkov

Abstract


Chronic heart failure (CHF) is a heterogeneous syndrome with a poor prognosis.

Aim of the work – to define predictors of body weight (BW) loss in patients with CHF and a reduced left ventricular ejection fraction (LVEF).

Materials and methods. 120 patients with stable CHF and LVEF ≤35 %, II-IV NYHA class were examined. Patients were divided into two groups according to the value of BW loss for 6 months: the first group - loss of BW <6 %, the second - ≥ 6 %.

Results. Out of the 120 patients who were studied, a BW loss of ≥ 6 % occurred in 59 (49.2 %) patients. According to the results of binary logistic regression, predictors of BW loss of ≥6 % in patients with CHF and LVEF ≤ 35 % were: age, coronary heart disease, anaemia, and the number of hospitalizations over the last year. People with poorer quality of life, bigger number of points on the Beck depression scale and DEFS, with lower levels of physical activity and worse endothelium-dependent vasodilator response; higher sizes of the right atrium, right ventricle, and pulmonary artery systolic pressure, E / E '. Higher levels of C-reactive protein (CRP), uric acid are associated with a risk of losing BW≥6 %.

Conclusions. Weight loss ≥ 6 % is observed in 49.2 % of patients with CHF and LVEF≤35 %. According to multivariate analysis, independent predictors of BW loss of ≥6 % in patients with CHF and LVEF≤35 % are age, CRP level, III-IV NYHA class, lower cholesterol levels, as well as lower rates of flow-dependent vasodilator response and hip circumference.


Keywords


chronic heart failure; weight loss; cardiac cachexia; predictors

Full Text:

PDF

References


Dube, P., Weber, K. T., Weber, K. T. (2011). Congestive Heart Failure: Pathophysiologic Consequences of Neurohormonal Activation and the Potential for Recovery: Part II. The American Journal of the Medical Sciences, 342 (6), 503–506. doi: http://doi.org/10.1097/maj.0b013e3182327527

Okoshi, M. P., Romeiro, F. G., Paiva, S. A., Okoshi, K. (2013). Heart failure induced cachexia. Arquivos Brasileiros De Cardiologia, 100, 476–482. doi: http://doi.org/10.5935/abc.20130060

Stewart Coats, A. J., Shewan, L. G. (2017). A comparison of research into cachexia, wasting and related skeletal muscle syndromes in three chronic disease areas. International Journal of Cardiology, 235, 33–36. doi: http://doi.org/10.1016/j.ijcard.2017.02.136

Anker, S. D., Negassa, A., Coats, A. J., Afzal, R., Poole-Wilson, P. A., Cohn, J. N., Yusuf, S. (2003). Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. The Lancet, 361 (9363), 1077–1083. doi: http://doi.org/10.1016/s0140-6736(03)12892-9

Song, E. K., Lee, Y., Moser, D. K., Dekker, R. L., Kang, S.-M., Lennie, T. A. (2014). The Link of Unintentional Weight Loss to Cardiac Event–Free Survival in Patients With Heart Failure. The Journal of Cardiovascular Nursing, 29 (5), 439–447. doi: http://doi.org/10.1097/jcn.0b013e3182a46ba8

Von Haehling, S., Anker, S. D. (2010). Cachexia as a major underestimated and unmet medical need: facts and numbers. Journal of Cachexia, Sarcopenia and Muscle, 1 (1), 1–5. doi: http://doi.org/10.1007/s13539-010-0002-6

Szabó, T., Postrach, E., Mähler, A., Kung, T., Turhan, G., von Haehling, S. et. al. (2013). Increased catabolic activity in adipose tissue of patients with chronic heart failure. European Journal of Heart Failure, 15 (10), 1131–1137. doi: http://doi.org/10.1093/eurjhf/hft067

Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S. et. al. (2016). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). European Heart Journal, 37 (27), 2129–2200. doi: http://doi.org/10.1093/eurheartj/ehw128

Voronkov, L. H. et. al. (Eds.) (2017). Rekomendatsii Asotsiatsii kardiolohiv Ukrainy z diahnostyky ta likuvannia khronichnoi sertsevoi nedostatnosti. Kyiv, 66.

Kovalenko, V. M., Ivaniv, Yu. A.; Kovalenko, V. M. et. al. (Eds.) (2015). Rekomendatsii robochoi hrupy z funktsionalnoi diahnostyky asotsiatsii kardiolohiv Ukrainy i Vseukrainskoi asotsiatsii fakhivtsiv z ekhokardiohrafii. Kyiv.

Stevens, L. A., Coresh, J., Greene, T., Levey, A. S. (2006). Assessing Kidney Function – Measured and Estimated Glomerular Filtration Rate. New England Journal of Medicine, 354 (23), 2473–2483. doi: http://doi.org/10.1056/nejmra054415

Voronkov, L. G., Parascheniuk, L. P. (2010). Kachestvo zhizni pri serdechnoi nedostatochnosti: aktualnye aspekty. Serceva nedostatnіst, 2, 12–16.

Gilarevsky, S. R., Orlov, V. A., Bendeliani, N. G., Hamaganova, L. K., Sycheva, E. Y. (2001). A Study of life quality in patients with chronic heart failure: the contemporary status. Russian Journal of Cardiology, 3, 58–72.

Vatutin, N. T., Kalinkina, N. V., Каrtamysheva, Ye. V., Khristichenko, M. A., Yeshchenko, Ye. V. (2013). Depressive disorders and chronic heart failure. Ukrainian Journal of Cardiology, 3, 117–124.

Tiesinga, L. J., Dassen, T. W. N., Halfens, R. J. G. (1998). DUFS and DEFS: development, reliability and validity of the Dutch Fatigue Scale and the Dutch Exertion Fatigue Scale. International Journal of Nursing Studies, 35 (1-2), 115–123. doi: http://doi.org/10.1016/s0020-7489(98)00005-4

Voronkov, L. G., Shkurat, I. A., Besaga, Е. M. (2005). Endothelium-dependent vasodilatation and its prognostic value in patients with chronic heart failure and left ventricular systolic dysfunction. Ukrainian Journal of Cardiology, 6, 86–90.

Cavey, J. (2011). Cardiac Cachexia. The Journal for Nurse Practitioners, 7 (7), 578–581. doi: http://doi.org/10.1016/j.nurpra.2011.04.018

Yamada, M., Nishiguchi, S., Fukutani, N., Tanigawa, T., Yukutake, T., Kayama, H. et. al. (2013). Prevalence of Sarcopenia in Community-Dwelling Japanese Older Adults. Journal of the American Medical Directors Association, 14 (12), 911–915. doi: http://doi.org/10.1016/j.jamda.2013.08.015

Melenovsky, V., Kotrc, M., Borlaug, B. A., Marek, T., Kovar, J., Malek, I., Kautzner, J. (2013). Relationships Between Right Ventricular Function, Body Composition, and Prognosis in Advanced Heart Failure. Journal of the American College of Cardiology, 62 (18), 1660–1670. doi: http://doi.org/10.1016/j.jacc.2013.06.046

Valentova, M., von Haehling, S., Krause, C., Ebner, N., Steinbeck, L., Cramer, L. et. al. (2013). Cardiac cachexia is associated with right ventricular failure and liver dysfunction. International Journal of Cardiology, 169 (3), 219–224. doi: http://doi.org/10.1016/j.ijcard.2013.08.134

Valentova, M., von Haehling, S., Bauditz, J., Doehner, W., Ebner, N., Bekfani, T. et. al. (2016). Intestinal congestion and right ventricular dysfunction: a link with appetite loss, inflammation, and cachexia in chronic heart failure. European Heart Journal, 37 (21), 1684–1691. doi: http://doi.org/10.1093/eurheartj/ehw008

Liu, X., Yin, S., Chen, Y., Wu, Y., Zheng, W., Dong, H. et. al. (2018). LPS‑induced proinflammatory cytokine expression in human airway epithelial cells and macrophages via NF‑κB, STAT3 or AP‑1 activation. Molecular Medicine Reports, 17 (4), 5484–5491. doi: http://doi.org/10.3892/mmr.2018.8542

Shrivastava, A. K., Singh, H. V., Raizada, A., Singh, S. K. (2015). C-reactive protein, inflammation and coronary heart disease. The Egyptian Heart Journal, 67 (2), 89–97. doi: http://doi.org/10.1016/j.ehj.2014.11.005

Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., Cook, N. R. (2002). Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events. New England Journal of Medicine, 347 (20), 1557–1565. doi: http://doi.org/10.1056/nejmoa021993

Kalogeropoulos, A., Georgiopoulou, V., Psaty, B. M., Rodondi, N., Smith, A. L., Harrison, D. G. et. al. (2010). Inflammatory Markers and Incident Heart Failure Risk in Older Adults: The Health, Aging, and Body Composition Study. Journal of the American College of Cardiology, 55 (19), 2129–2137. doi: http://doi.org/10.1016/j.jacc.2009.12.045

Anand, I. S., Latini, R., Florea, V. G., Kuskowski, M. A., Rector, T., Masson, S. et. al. (2005). C-Reactive Protein in Heart Failure Prognostic Value and the Effect of Valsartan. Circulation, 112 (10), 1428–1434. doi: http://doi.org/10.1161/circulationaha.104.508465

Sproston, N. R., Ashworth, J. J. (2018). Role of C-Reactive Protein at Sites of Inflammation and Infection. Frontiers in Immunology, 9. doi: http://doi.org/10.3389/fimmu.2018.00754

Eklund, C. M. (2009). Chapter 5 Proinflammatory cytokines in CRP baseline regulation. Advances in Clinical Chemistry, 48, 111–136. doi: http://doi.org/10.1016/s0065-2423(09)48005-3

Yamauchi-Takihara, K., Ihara, Y., Ogata, A., Yoshizaki, K., Azuma, J., Kishimoto, T. (1995). Hypoxic Stress Induces Cardiac Myocyte–Derived Interleukin-6. Circulation, 91 (5), 1520–1524. doi: http://doi.org/10.1161/01.cir.91.5.1520

Deokar, S. A., Dandekar, S. P., Shinde, G. A., Prabhu, S. S., Patawardhan, M. (2018). Role of serum interleukin-6 in heart failure. International Journal of Advances in Medicine, 5 (4), 936–940. doi: http://doi.org/10.18203/2349-3933.ijam20183123

Sproston, N. R., El Mohtadi, M., Slevin, M., Gilmore, W., Ashworth, J. J. (2018). The Effect of C-Reactive Protein Isoforms on Nitric Oxide Production by U937 Monocytes/Macrophages. Frontiers in Immunology, 9. doi: http://doi.org/10.3389/fimmu.2018.01500

Pasceri, V., Willerson, J. T., Yeh, E. T. H. (2000). Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells. Circulation, 102 (18), 2165–2168. doi: http://doi.org/10.1161/01.cir.102.18.2165

Fedele, F., Mancone, M., Chilian, W. M., Severino, P., Canali, E., Logan, S. et. al. (2013). Role of genetic polymorphisms of ion channels in the pathophysiology of coronary microvascular dysfunction and ischemic heart disease. Basic Research in Cardiology, 108 (6). doi: http://doi.org/10.1007/s00395-013-0387-4

Park, K.-H., Park, W. J. (2015). Endothelial Dysfunction: Clinical Implications in Cardiovascular Disease and Therapeutic Approaches. Journal of Korean Medical Science, 30 (9), 1213–1225. doi: http://doi.org/10.3346/jkms.2015.30.9.1213

Landmesser, U., Spiekermann, S., Dikalov, S., Tatge, H., Wilke, R., Kohler, C. et. al. (2002). Vascular Oxidative Stress and Endothelial Dysfunction in Patients With Chronic Heart Failure. Circulation, 106 (24), 3073–3078. doi: http://doi.org/10.1161/01.cir.0000041431.57222.af

Timmerman, K. L., Volpi, E. (2013). Endothelial function and the regulation of muscle protein anabolism in older adults. Nutrition, Metabolism and Cardiovascular Diseases, 23, S44–S50. doi: http://doi.org/10.1016/j.numecd.2012.03.013

Dos Santos, M. R., Saitoh, M., Ebner, N., Valentova, M., Konishi, M., Ishida, J. et. al. (2017). Sarcopenia and Endothelial Function in Patients With Chronic Heart Failure: Results From the Studies Investigating Comorbidities Aggravating Heart Failure (SICA-HF). Journal of the American Medical Directors Association, 18 (3), 240–245. doi: http://doi.org/10.1016/j.jamda.2016.09.006

Zhao, Q., Li, J., Yang, J., Li, R. (2017). Association of total cholesterol and HDL-C levels and outcome in coronary heart disease patients with heart failure. Medicine, 96 (9), e6094. doi: http://doi.org/10.1097/md.0000000000006094

Azhar, G., Wei, J. Y. (2013). New Approaches to Treating Cardiac Cachexia in the Older Patient. Current Cardiovascular Risk Reports, 7 (6), 480–484. doi: http://doi.org/10.1007/s12170-013-0353-6

Wright, F. L., Green, J., Reeves, G., Beral, V., Cairns, B. J. (2015). Validity over time of self-reported anthropometric variables during follow-up of a large cohort of UK women. BMC Medical Research Methodology, 15 (1). doi: http://doi.org/10.1186/s12874-015-0075-1




DOI: http://dx.doi.org/10.21303/2504-5679.2019.00999

Refbacks

  • There are currently no refbacks.




Copyright (c) 2019 Ekaterina Voitsekhovskayа, Leonid Voronkov

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2504-5679 (Online), ISSN 2504-5660 (Print)